189 related articles for article (PubMed ID: 28685877)
1. Availability of immunocytochemistry using cocktail antibody targeting p63/cytokeratin14 for the differential diagnosis of fibroadenoma and ductal carcinoma in situ in fine needle aspiration cytology of the breast.
Maeda I; Oana Y; Tsugawa K; Takagi M
Cytopathology; 2017 Oct; 28(5):378-384. PubMed ID: 28685877
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
Tanaka S; Kanomata N; Teramura K; Wakita K; Kunihisa T; Yano Y; Moriya T; Hayashi Y
Cytopathology; 2016 Dec; 27(6):465-471. PubMed ID: 27060708
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
[TBL] [Abstract][Full Text] [Related]
4. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
5. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
6. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
[TBL] [Abstract][Full Text] [Related]
7. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.
Wang HH; Ducatman BS; Eick D
Am J Clin Pathol; 1989 Dec; 92(6):736-40. PubMed ID: 2556017
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
[TBL] [Abstract][Full Text] [Related]
9. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
Niu F; Wang L; Zhang W; Lyu S; Niu Y
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
[TBL] [Abstract][Full Text] [Related]
10. Fractal Analysis Method for the Complexity of Cell Cluster Staining on Breast FNAB.
Yoshioka H; Herai A; Oikawa S; Morohashi S; Hasegawa Y; Horie K; Watanabe J
Acta Cytol; 2021; 65(1):4-12. PubMed ID: 32841946
[TBL] [Abstract][Full Text] [Related]
11. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: A case report.
Shojaku H; Hori R; Yoshida T; Matsui K; Shimada K; Takayanagi N; Noguchi K
Medicine (Baltimore); 2021 Mar; 100(10):e24023. PubMed ID: 33725814
[TBL] [Abstract][Full Text] [Related]
12. The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
Reisenbichler ES; Ross JR; Hameed O
Ann Diagn Pathol; 2014 Dec; 18(6):313-8. PubMed ID: 25224390
[TBL] [Abstract][Full Text] [Related]
13. Fibroadenoma masquerading carcinoma on fine-needle aspiration of the breast.
Tamiolakis D; Georgiou G; Barbagadaki S; Antoniou Ch; Nikolaidou S; Tsiminikakis N; Economou C; Bolioti S; Alifieris E
Chirurgia (Bucur); 2008; 103(2):227-30. PubMed ID: 18457104
[TBL] [Abstract][Full Text] [Related]
14. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy.
Clark AJ; Petty HR
Sci Rep; 2016 Jun; 6():27039. PubMed ID: 27247112
[TBL] [Abstract][Full Text] [Related]
15. Inconclusive or erroneous fine-needle aspirates of breast with adequate and representative material: a cytologic/histologic study.
Shabb NS; Boulos FI; Chakhachiro Z; Abbas J; Abdul-Karim FW
Diagn Cytopathol; 2014 May; 42(5):405-15. PubMed ID: 24167007
[TBL] [Abstract][Full Text] [Related]
16. An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma
Marumoto A; Steinemann S; Furumoto N; Woodruff S
Hawaii J Med Public Health; 2019 Feb; 78(2):39-43. PubMed ID: 30766763
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of computer-aided diagnosis (CADx) of breast pathology using immunohistochemistry results of core needle biopsy samples for synaptophysin, oestrogen receptor and CK14/p63 for classification of epithelial proliferative lesions of the breast.
Maeda I; Kubota M; Ohta J; Shinno K; Tajima S; Ariizumi Y; Doi M; Oana Y; Kanemaki Y; Tsugawa K; Ueno T; Takagi M
J Clin Pathol; 2017 Dec; 70(12):1057-1062. PubMed ID: 28630050
[TBL] [Abstract][Full Text] [Related]
18. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
19. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
20. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]